Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
Latest Information Update: 09 Apr 2025
At a glance
- Drugs 68-Ga-FAPI-46 (Primary)
- Indications Liver cancer
- Focus Diagnostic use
Most Recent Events
- 04 Apr 2025 Planned End Date changed from 1 Dec 2025 to 1 Feb 2026.
- 04 Apr 2025 Planned primary completion date changed from 1 Mar 2025 to 1 Aug 2025.
- 04 Apr 2025 Status changed from not yet recruiting to recruiting.